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Abstract We have recently identified an Arabidopsis thaliana
cDNA encoding a putative protein Ser/Thr phosphatase PP7, not
closely related to any protein phosphatases in animals or fungi.
Here, we describe the characterization of PP7 expressed in a
bacterial system. The recombinant protein was inactive unless the
longest insert in its catalytic domain was cleaved, suggesting that
this insert is an autoinhibitory region. PP7 was resistant to
okadaic acid, calyculin and fumonisin B1, and was stimulated by
Mn2+ or Fe2+, while Ni2+ and Zn2+ were inhibitory. Polylysine
stimulated PP7 activity towards p-nitrophenylphosphate but
inhibited activity towards the most efficient protein substrate,
myelin basic protein. A tentative model of the control of PP7
activity is proposed.
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1. Introduction
Protein Ser/Thr phosphatases have been implicated in a
great variety of cellular processes in plants (for reviews, see
[1,2]). A number of plant protein phosphatases (PP) of the
PPP family [3] have been cloned including PPX and multiple
isoforms of catalytic subunits of PP1 and PP2A, as well as
regulatory subunits of some of them [3]. All these enzymes
have structural homologues in animals, although precise func-
tions of most of them in plants have not been clari¢ed. Phos-
phatases of di¡erent PPP subfamilies are characterized by
di¡erent sensitivities to several phosphatase inhibitors, some
of which are commonly used to ascribe observed e¡ects to
certain phosphatase types (see references in [3]).
Arabidopsis thaliana PP7 cDNA encoding a putative novel
protein Ser/Thr phosphatase has recently been described [4].
While PP7 is a member of the PPP family, no closely related
structures have been found so far in animals or fungi. De-
tailed comparison of PP7 to other PPP phosphatases indicates
that it is structurally more similar to the enzymes of the rdgC/
PP5 subfamily [4,5]. The unique features of PP7 include an N-
terminal domain which has no signi¢cant similarity to any
sequence present in the databases, as well as three inserts in
the C-terminal part of its catalytic domain; the latter region is
thought to interact with regulators and substrates in PPP
phosphatases [6].
These structural peculiarities of PP7, as well as ample evi-
dence accumulated about the e¡ects of phosphatase inhibitors
on various functions in the plant cells, prompted us to under-
take expression of this phosphatase in a heterologous system
and characterization of its enzymatic activity as a part of our
ongoing work aimed at analysis of PP7 function in vivo. Here,
we describe expression in Escherichia coli and biochemical
characterization of recombinant A. thaliana PP7. The results
demonstrate that PP7 is an active protein Ser/Thr phospha-
tase and provide a set of characteristics that may be helpful in
analysis of PP7 function in the plant cell.
2. Materials and methods
2.1. Construction of vectors for PP7 expression in E. coli
A cDNA fragment encoding the putative catalytic domain of PP7
(Gln40 to Ser367) was obtained by PCR using the clone 122A12T7
[4]. A BamHI-SalI PCR fragment was cloned into respective restric-
tion sites of the expression vector pQE9 (Qiagen).
The complete open reading frame encoding PP7 was assembled in
pBluescript II SK(+) (Stratagene) as follows. A HincII-EcoRI frag-
ment (including the coding sequence from Asn48 and 179 bp 3P non-
coding region) obtained using clone 122A12T7 was cloned in pBlue-
script II SK(+) vector to generate pAS64. To obtain the missing N-
terminal sequence, the construct pAS63, carrying a 5P-RACE frag-
ment [4], was chosen as a template. Oligonucleotides 5P-CCGTCGA-
CACTGTTCCACCATCTCCC-3P and 5P-AAGATCATCGATAT-
GAACGCAG-3P were used to generate the SalI (HincII) site
(italicized) in front of the ACT triplet encoding Thr3 (underlined)
and HincII site (GTCAAC, encoding Val47 and Asn48) as the inter-
nal part of the PCR fragment. The HincII fragment was cloned in
pAS64 digested with HincII, resulting in pAS65. Correct assembly of
the PP7 open reading frame in pAS65 was checked by sequencing.
PP7 was recloned as a SalI-PstI fragment (where the PstI site is a part
of pBluescript II SK(+) polylinker) in pQE9 to generating the con-
struct pQE9/PP7.
E. coli M15 cells carrying pQE9/PP7 were grown at 37‡C until the
absorbance at 600 nm reached 0.7^0.9. Isopropylthiogalactoside was
then added to a ¢nal concentration of 25 WM, and the culture was
grown for an additional 3 h (at 37‡C or 25‡C) or overnight at 8‡C.
2.2. Puri¢cation of recombinant PP7
Cell lysis and recombinant PP7 puri¢cation under denaturing or
native conditions were performed essentially according to Qiagen in-
structions. Ni-IDA Sepharose (Sigma) was used instead of Ni-NTA
agarose. Benzamidine (1 mM), PMSF (125 WM) and pepstatin (2 WM)
were added to all solutions used for puri¢cation under native condi-
tions, and all procedures were done at 0^4‡C. PP7 containing frac-
tions from Ni-IDA Sepharose chromatography were diluted 10-fold
with water containing protease inhibitors and dithiothreitol (1 mM)
and applied on a DEAE Sepharose (Sigma) column equilibrated in
5 mM HEPES (pH 7.6), 1 mM dithiothreitol. Proteins were eluted by a
stepwise salt gradient in the same bu¡er (100, 150, 200, 250, 300, 400
and 500 mM NaCl), and fractions analyzed for protein composition
and phosphatase activity. The presence of the His6 tag in the protein
was determined by Western blotting with PentaWHis or RGSWHis
monoclonal antibodies (Qiagen). Detection was performed using
ECL detection kit (Amersham).
N-terminal sequencing of the protein transferred onto Immobilon P
membrane (Millipore) was carried out at Alta Bioscience (Birming-
ham, UK).
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2.3. Phosphatase assays
Phosphorylated substrates were prepared using [Q-33P]ATP (NEN)
as follows. Protein substrates (except rhodopsin) and kinases (except
rhodopsin kinase) were purchased from Sigma. Myelin basic protein,
casein and mixed histones were phosphorylated by the catalytic sub-
unit of protein kinase A. Reaction mixtures (100 Wl) contained 40 mM
HEPES (pH 7.4), 0.1 mM EGTA, 10 mM magnesium acetate, 10 mM
dithiothreitol, 0.1 mM [Q-33P]ATP (5^10 WCi), 5 mg/ml substrate, and
catalytic subunit of protein kinase A (30 U). Reactions were incubated
at 30‡C for 2.5 h (myelin basic protein and histone) or 24 h (casein).
Phosphorylase b was phosphorylated by phosphorylase kinase accord-
ing to [7]. Free ATP was separated and bu¡er changed on NAP-5
desalting columns (Pharmacia) equilibrated in 5 mM HEPES (pH
7.4), 100 mM NaCl. Puri¢cation of bovine rod outer segments and
phosphorylation of rhodopsin by endogenous rhodopsin kinase were
performed as described elsewhere [8].
Protein phosphatase activity was assayed in a ¢nal volume of 25^50
Wl at 25‡C with substrate concentrations corresponding to 5 WM 33Pi
and appropriate amounts of PP7-containing fractions to ensure line-
arity of the 33Pi release with time and PP7 concentration. When nec-
essary, additions were used as speci¢ed in the ¢gure legends. Okadaic
acid, calyculin A and fumonisin B1 (all from Sigma) were added in
methanol; the ¢nal methanol concentration in the reaction mixtures
(4%) did not a¡ect PP7 activity.
p-Nitrophenylphosphate hydrolysis was measured by diluting ap-
propriate amounts of PP7 (typically 15^40 Wl) in a bu¡er containing
(unless otherwise indicated in the ¢gure legends) 20 mM HEPES (pH
7.8), 0.5 mM MnCl2, 1 mM dithiothreitol and 1 mM p-nitrophenyl-
phosphate (total volume 800 Wl). p-Nitrophenol formation was fol-
lowed by absorbance increase at 410 nm. p-Nitrophenol extinction
coe⁄cients at di¡erent pHs were determined experimentally using 40
WM p-nitrophenol.
Since the half-life of puri¢ed PP7 (kept either on ice or at 320‡C in
50% glycerol) was V20 h, all phosphatase assays were done on the
same or the next day after puri¢cation.
3. Results
3.1. Expression and puri¢cation of PP7
Initially, we attempted to express the putative catalytic do-
main of PP7 without N- and C-terminal extensions (residues
40^367) to avoid potential problems caused by the possible
presence of autoinhibitory sites in the N- or C-terminal ex-
tensions, which are found in some PPP phosphatases [9^11].
This resulted in a high yield expression (20^30 mg/l of bacte-
rial culture) of the recombinant protein which was, however,
found entirely in inclusion bodies. No increased phosphatase
activity could be detected in the supernatants of the cells ex-
pressing PP7 catalytic domain as compared to the control
cells. The recombinant PP7 fragment contained the N-termi-
nally attached His6 tag and could be easily puri¢ed from in-
clusion bodies under denaturing conditions (not shown). Yet,
neither of the approaches used to renature the protein was
successful. It appeared therefore that some regions in the N-
or C-terminal domains may be essential for correct protein
folding.
As a next step, we attempted expression of the complete
PP7 open reading frame in the same system. While signi¢cant
amounts of recombinant protein of the expected molecular
mass (V50 kDa) were found in the inclusion bodies, crude
lysates of the induced cultures transformed with the pQE9/
PP7 construct showed 10^30-fold increased phosphatase ac-
tivity towards p-nitrophenylphosphate as compared to the
cells transformed with pQE9 plasmid carrying no insert
(Fig. 1A). This phosphatase activity was completely depend-
ent on the presence of Mn2 (see below), was retained by Ni-
IDA Sepharose and could be eluted at high imidazole concen-
trations (Fig. 1A), which indicated speci¢c binding provided
by the His6 tag. In contrast, the phosphatase activity in the
control cell lysates was Mn2-independent and did not bind to
the Ni-IDA Sepharose. Formation of inclusion bodies was
completely suppressed if the cells were induced at tempera-
tures below 15‡C, but this also led to reduced levels of the
active phosphatase. Therefore, induction was routinely carried
out at 25‡C, which yielded 1^2 mg of active protein per liter
of bacterial culture.
Fractions eluted from the Ni-IDA Sepharose contained a
protein of the same molecular mass (V50 kDa) as the main
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Fig. 1. Puri¢cation of PP7 expressed in E. coli. A: Fractions from Ni-IDA Sepharose chromatography were assayed for phosphatase activity
with p-nitrophenylphosphate and analyzed by SDS-PAGE (inset). Empty bars, E. coli transformed with pQE9; stippled bars, E. coli trans-
formed with pQE9/PP7. 1, crude E. coli extract; 2, £ow-through fraction; 3, 4, 5 and 6, fractions eluted with 10, 40, 250 and 400 mM imida-
zole, respectively; 7, PP7 puri¢ed from inclusion bodies; 8, fraction 5 probed with PentaWHis antibody. B: DEAE Sepharose chromatography
of the protein eluted from Ni-IDA Sepharose with 250 mM imidazole. Lanes in the inset correspond to the fractions eluted with the following
NaCl concentrations: 1, 150 mM; 2, 200 mM; 3, 250 mM; 4, 300 mM; 5, 400 mM; 6, 500 mM. C: PP7 eluted from DEAE Sepharose (frac-
tion 2) analyzed by SDS-PAGE in the presence of 0.1 M dithiothreitol (lane 1) or in the absence of reducing agents (lane 2).
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component of the inclusion bodies (i.e. the presumable re-
combinant PP7), two bands of V28 and V25 kDa and var-
iable amounts of contaminant proteins (Fig. 1A, inset). The
50 kDa and 28 kDa bands were recognized by monoclonal
antibodies against the N-terminus of the proteins expressed in
pQE9 and recognizing epitopes HHHHH (Fig. 1A, inset) or
RGSHHHH (data not shown). Proteins eluted from Ni-IDA
Sepharose were separated further by DEAE Sepharose chro-
matography, and activity of the fractions was assayed with p-
nitrophenylphosphate. Surprisingly, phosphatase activity was
not associated with theV50 kDa band eluted at 300^400 mM
NaCl, but rather with two proteins of V28 and V25 kDa
eluted at 200^250 mM NaCl (Fig. 1B). The presence of the
histidine tag in the 28 kDa protein indicated that it was likely
to represent the N-terminal half of PP7. N-terminal sequenc-
ing of the 25 kDa band revealed a sequence RVVLL found in
the middle of the ¢rst of the three inserts present in the PP7
catalytic domain [4]. Thus, intact recombinant PP7 appears to
have no detectable phosphatase activity but can be activated
by proteolytic cleavage of the insert separating the N- and C-
terminal portions of the catalytic domain.
In the absence of reducing agents, the electrophoretic mo-
bility of the 25 kDa band was not a¡ected, while the 28 kDa
protein formed a di¡use band with an apparent molecular
mass of 26^27 kDa (Fig. 1C). This observation indicates
that the N-terminal fragment of the recombinant PP7 con-
tains an intramolecular disul¢de bond. Since no disul¢de
bond formation has been described within the catalytic do-
mains of the PPP phosphatases, the most likely candidates for
the residues involved are Cys28 and Cys67 in the N-terminal
domain of PP7.
Entire PP7 could be puri¢ed from inclusion bodies under
denaturing conditions and refolded by two-step dialysis (urea
gradients 8 MC1 M and 1 MC2 mM). This procedure
yielded v80% soluble protein; however, renatured entire
PP7 exhibited no detectable phosphatase activity (data not
shown).
3.2. PP7 as a protein Ser/Thr phosphatase
The fact that PP7 shares signi¢cant sequence similarity with
the protein phosphatases of the PPP family [2] suggested that
this enzyme is likely to function as a protein Ser/Thr phos-
phatase. Indeed, puri¢ed recombinant PP7 was able to de-
phosphorylate, besides p-nitrophenylphosphate, a number of
protein substrates phosphorylated at Ser and/or Thr residues
(Fig. 2). Of the phosphoproteins tested, myelin basic protein
phosphorylated by protein kinase A was the most e⁄cient
PP7 substrate. PP7 was inhibited by NaF (IC50 V3 mM)
and orthovanadate, which completely abolished phosphatase
activity at 10 WM concentration (data not shown).
3.3. E¡ects of divalent cations, pH and phosphatase inhibitors
Of several divalent cations tested, only Mn2 and Fe2 were
able to stimulate PP7 activity (Fig. 3). No PP7 activity could
be detected with p-nitrophenylphosphate in the absence of
added Mn2. Half-e¡ective Mn2 concentrations (Fig. 3A)
were similar for protein substrates (V20 WM) and p-nitrophen-
ylphosphate (V25 WM). Mn2-stimulated PP7 was strongly
inhibited by Ni2 and Zn2, while Mg2, Ca2 and Fe2 had
slight or moderate inhibitory e¡ects (Fig. 3A). An equimolar
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Fig. 3. E¡ects of divalent cations on PP7 activity. A: E¡ects of di-
valent cations on the phosphatase activity of PP7. Myelin basic pro-
tein was incubated with PP7 (180 nM) at pH 7.2 in the absence
(empty bars) or in the presence (stippled bars) of MnCl2 (100 WM)
without or with addition of CaCl2 (200 WM), MgCl2 (2 mM), NiCl2
(200 WM), FeSO4 (200 WM), ZnCl2 (200 WM) or a mixture of FeSO4
and ZnCl2 (100 WM each) as indicated. Results are shown as per-
centages of the activity in the presence of 100 WM MnCl2. The bars
represent the means from three aliquots (values indicated by hori-
zontal lines). B: Stimulation of PP7 activity by Mn2. Substrates
used were p-nitrophenylphosphate (b), myelin basic protein (O) or
casein (a). Activity was assayed at pH 7.8 for p-nitrophenylphos-
phate and pH 7.2 for protein substrates in the presence of PP7 (20
nM and 200 nM, respectively) and various concentrations of
MnCl2. Results are shown as percentages of the maximal activity
for each substrate.
Fig. 2. Time course of dephosphorylation of myelin basic protein
(R), casein (F), phosphorylase a (O), rhodopsin (a) and histone
IIA (E) by puri¢ed recombinant PP7 (130 nM). The reaction was
carried out at pH 7.0 in the presence of MnCl2 (0.5 mM).
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mixture of Fe2 and Zn2, which is e¡ective in the activation
of recombinant PP1 [12], failed to activate PP7 (Fig. 3B) and
was as inhibitory for the Mn2-stimulated enzyme as Zn2
alone (data not shown).
When assayed with p-nitrophenylphosphate, Mn2-stimu-
lated PP7 exhibited maximal activity at pH 7.6^7.8 (data
not shown). However, with protein substrates the pH opti-
mum was shifted to 6.8 for casein and 7.2 for myelin basic
protein (Fig. 4).
PP7 activity assayed with myelin basic protein or casein was
resistant to inhibition by such widely used inhibitors of PPP
phosphatases as okadaic acid (20 WM) and calyculin (20 WM).
Fumonisin B1, a mycotoxin recently found to inhibit, with
di¡erent a⁄nities, all tested PPP phosphatases as well as
PP2C [13], slightly activated PP7 at 2 mM concentration
(data not shown).
3.4. E¡ects of heparin and polylysine
PP7 was una¡ected by heparin at a concentration of 0.5
mg/ml (data not shown). In contrast, it was e⁄ciently inhib-
ited by polylysine when tested with myelin basic protein and
activated when tested with p-nitrophenylphosphate (Fig. 5).
Apparent a⁄nities of polylysine binding were similar, inde-
pendently of whether this caused activation or inhibition
(EC50 0.15^0.2 Wg/ml for 300 kDa polylysine, data not shown;
EC50 1.5^3 Wg/ml for 1 kDa polylysine, which corresponds to
1.5^3 WM hexapeptide, Fig. 5).
4. Discussion
We have expressed in E. coli and characterized recombinant
PP7, a novel phosphatase from A. thaliana. PP7 shares overall
sequence similarity in its catalytic domain with the phospha-
tases of the PPP family but is not a close relative of any other
PPP phosphatase [4]. Our preliminary observations that the
highest levels of PP7 expression are found in the guard cells
(Andreeva et al., in preparation), together with its unique
structural features [4], make its further characterization of
signi¢cant interest.
The fact that the recombinant PP7 is not active unless the
¢rst of the three inserts in its catalytic domain is cleaved
indicates that this insert may function as an autoinhibitory
region. Autoinhibitory regions which can be eliminated by
limited proteolysis are known in a number of PPP phospha-
tases such as calcineurin [9], PPZ [10] and PP5 [11], but in all
the cases described previously these sequences are located out-
side the catalytic domain. PP7 is the ¢rst phosphatase which
appears to possess an autoinhibitory region inserted in the
middle of its catalytic domain.
A working model of how PP7 activity may be controlled
can be suggested on the basis of the following observations:
(i) PP7 is activated by proteolytic cleavage of the ¢rst insert
containing a stretch of positively charged residues; basic re-
gions in analogous positions are conserved in the putative PP7
homologues from rice [4] and watermelon (‘expressed se-
quence tag’ AA660123); (ii) the most e⁄cient substrate is
myelin basic protein; (iii) polylysine activates hydrolysis of
p-nitrophenylphosphate and inhibits dephosphorylation of
myelin basic protein with similar a⁄nity. These observations
may be accounted for if one postulates that PP7 structure is
optimized for binding basic substrates, and this binding stim-
ulates (probably allosterically) substrate dephosphorylation.
Furthermore, polylysine would bind at the same site as the
basic substrates and mimic substrate binding, thus increasing
the e⁄ciency of the catalysis and activating hydrolysis of p-
nitrophenylphosphate. In the case of myelin basic protein,
polylysine binding would still stimulate catalysis but, at the
same time, would prevent e⁄cient binding of the protein sub-
strate to the same site, thus decreasing overall e⁄ciency of
dephosphorylation. The autoinhibitory action of the ¢rst in-
sert would rely on a similar mechanism: it seems likely that
the stretch of positively charged residues found at the N-ter-
minus of the ¢rst insert in PP7 may mimic substrate binding
and allow targeting of another sequence (one candidate may
be the C-terminal part of the same insert) to block the active
center.
Another PPP phosphatase which prefers basic substrates is
PP1, and it has been suggested to bind positively charged
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Fig. 5. Inhibition of PP7 activity by polylysine. PP7 (40 nM) was
incubated with myelin basic protein (R) at pH 7.2 or with pNPP
(b) at pH 7.8 in the presence of MnCl2 (0.5 mM) and various con-
centrations of polylysine. Results are shown as percentages of the
activity in the absence of polylysine.
Fig. 4. pH dependence of PP7 activity. The activity was assayed
with casein (F) or myelin basic protein (R) in the presence of
MnCl2 (0.5 mM). PP7 concentration was 40 nM for myelin basic
protein and 200 nM for casein. Bu¡ers used (80 mM) were MES,
pH 5.5^6.5; HEPES, pH 6.7^8.0; Tris-HCl, pH 8.15^8.6. Results
are shown as percentages of the maximal activity for each substrate.
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substrates at the acidic groove constituted by several Asp and
Glu residues [12]. Most of these residues are not conserved in
PP7 (see alignment in [4]) and, therefore, the mechanisms of
binding basic substrates and precise requirements for sub-
strate structure in these two phosphatases are probably di¡er-
ent. This is supported by the fact that histones, e⁄ciently
dephosphorylated by PP1 [14], are quite poor substrates for
PP7.
While cleavage of the autoinhibitory regions/domains is
known to activate a number of protein phosphatases in vitro,
none of them has been shown to be proteolytically processed
in vivo. The accessibility of the ¢rst insert in PP7 for proteol-
ysis probably indicates that this region is on the surface of the
folded protein and would also be easily accessible from the
solvent in vivo, which might allow its cleavage by endogenous
plant proteases. It can be speculated that, after such ‘constit-
utive’ activation, the phosphatase may be controlled by regu-
latory proteins acting as competitive inhibitors. Alternatively,
regulatory proteins might bind to the entire PP7 and release
the autoinhibition. Both in PP7 from A. thaliana and in its
putative homologue from rice [4], two Thr and/or Ser are
found in the positively charged N-terminal portions of the
inserts. In A. thaliana PP7, the insert contains a potential
site of phosphorylation by protein kinase A (KRTT).
Although our attempts to phosphorylate entire PP7 by puri-
¢ed bovine protein kinase A resulted in only low substoichio-
metric phosphate incorporation (data not shown), these Thr
residues may represent potential sites of phosphorylation by
endogenous plant kinases. Phosphorylation of these residues
can be expected to reduce the overall basic character of the
site and possibly release phosphatase inhibition.
Human and mouse phosphatases PPEF-2 are retrieved as
the highest scoring sequences when protein sequence data-
bases are searched with the sequence of PP7 catalytic domain
using the BLAST algorithm [15]. PPEF-2, like other rdgC-
related phosphatases, possesses inserts of variable length in
a position adjacent to the position of the ¢rst insert in plant
PP7 [16]. Interestingly, despite the di¡erent lengths of the
inserts in PPEF-2 and PP7, the distribution of the charged
residues in these sequences is similar: basic residues are clus-
tered at the N-termini of the inserts, while their C-terminal
parts are neutral or negatively charged. Both in plant PP7 and
in PPEF-2 sequence conservation between di¡erent species is
lower in the inserts than in the surrounding regions of the
molecule [4,16], but this characteristic charge distribution is
preserved. Biochemical characterization of PPEF-2 is not yet
available, and it is not known whether the inserts in these
phosphatases may play any regulatory role.
The preference of PP7 for positively charged substrates may
account for the di¡erent pH optima for dephosphorylation of
phosphoproteins and p-nitrophenylphosphate. While the opti-
mal pH for p-nitrophenylphosphate hydrolysis (7.6^7.8) prob-
ably re£ects requirements of the catalytic center itself, the shift
of the pH optimum for dephosphorylation of phosphopro-
teins to pH 6.8^7.2 may be due to the requirement of proto-
nation of some substrate residues for more e⁄cient binding to
PP7. An interesting implication of such pH dependence is
possible regulation of PP7 by pH in vivo. In the guard cells,
pH is thought to increase in response to abscisic acid and
possibly other stimuli [17^19]. These stimulus-dependent pH
changes have been suggested to regulate activity of ABI1 [20],
a protein Ser/Thr phosphatase related to the PPM family and
essential for abscisic acid signal transduction in stomata [21].
When tested with phosphorylated casein as a substrate, ABI1
exhibits maximal activity at pH 8 and is thus expected to be
activated by cytoplasm alkalinization in vivo [20]. In contrast,
in the case of PP7, a pH increase would rather result in a
decrease in phosphatase activity. Thus, while dephosphoryla-
tion of ABI1 substrates (which have not yet been identi¢ed) is
expected to increase in response to cytoplasm alkalinization,
dephosphorylation of the substrates of PP7 would rather de-
crease.
Unlike PP2C-related phosphatases, PP7 is not activated
and is even slightly inhibited by millimolar concentrations of
Mg2. The results of the experiments with divalent cations
strongly suggest that the dinuclear metal center in PP7 is un-
likely to be Fe2/Zn2 as in PP2B [22], since the mixture of
Fe2 and Zn2 failed to activate the phosphatase, and Zn2
inhibited PP7 activated by Fe2 or Mn2. The fact that only
the latter two ions were e⁄cient activators of PP7 indicates
that one or both of them may be present in the catalytic
center of PP7 in vivo.
PP7 is resistant to such commonly used phosphatase inhib-
itors as okadaic acid and calyculin, as well as fumonisin B1,
recently shown to inhibit several PPP phosphatases and PP2C.
PP7 insensitivity to high concentrations of okadaic acid and
calyculin clearly distinguishes it from PPP phosphatases re-
lated to PP1, PP2A and PP5 (which are inhibited by subna-
nomolar or nanomolar concentrations of these inhibitors
[10,23^26]) and also PP2B (which is half inhibited at 5 WM
okadaic acid [24]). Human PPEF-1 has been reported to be
insensitive to okadaic acid and calyculin [27] but the concen-
tration of okadaic acid used in this work (1 WM) is insu⁄cient
to compare the sensitivity of PPEF-1 with that of PP2B. Two
putative novel protein Ser/Thr phosphatases from animals,
which dephosphorylate rhodopsin [8] and Ca2/calmodulin-
dependent protein kinase II [28], respectively, are not a¡ected
by okadaic acid concentrations up to 10 WM. However, these
enzymes have not yet been identi¢ed at the molecular level.
Intriguingly, Ca2/calmodulin-dependent protein kinase phos-
phatase is stimulated by polylysine with an apparent a⁄nity
similar to that for regulation of PP7 [28].
The characterization of the recombinant A. thaliana PP7
described here demonstrates that it is a functional protein
Ser/Thr phosphatase. The availability of a distinctive set of
biochemical characteristics, together with our ongoing study
of the PP7 expression pattern in A. thaliana and work on
production of transgenic plants, should help to clarify the
role(s) PP7 plays in the plant cell. Further work will be nec-
essary to test and re¢ne the model of PP7 activity control
proposed here and establish how this phosphatase is regulated
in vivo.
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